IL17A and COVID-19: At very high exposure level (Supplementary Figure S3), COVID-19-positive individuals demonstrated a continuous increase in IFN-γ, IL-2, IL-6, and IL-17A, while TNF peaked early and IL-10 showed minimal expression.